Factors associated with successful medication discontinuation after a randomized clinical trial of relapse prevention in first-episode psychosis: A 10-year follow-up
JAMA Feb 13, 2019
Hui CLM, et al. - Given that not all patients with psychotic disorders require a lifetime of antipsychotic treatment, researchers reported the proportion and factors associated with successful discontinuation during long-term follow-up of patients with first-episode psychosis. A study of patients in the schizophrenia spectrum found that 24 out of 70 (34%) were free of antipsychotic medication for at least 3 months after an average disease duration of 10.4 years, of which 20 were medication-free for more than one year. Another study of first-episode psychosis reported that that 17 of 103 patients (16.5%) had stopped the antipsychotic medication in the previous two years during the seven-year follow-up. It is of considerable importance to identify clinical characteristics of disease associated with a lower or higher probability of successfully discontinuing the antipsychotic medication.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries